Market Place
Sourcing Support
ProKidney to Attend Guggenheim & Jefferies Healthcare Conferences
05 Nov 2024 //
GLOBENEWSWIRE
ProKidney Announces Five Abstracts Selected For ASN Kidney 2024
14 Oct 2024 //
GLOBENEWSWIRE
ProKidney to Participate in the UBS Virtual Organ Restoration Day
09 Oct 2024 //
GLOBENEWSWIRE
ProKidney halts one CKD cell therapy ph 3 trial & surplus to FDA approval
04 Sep 2024 //
GLOBENEWSWIRE
ProKidney To Participate In Morgan Stanley Global Healthcare Conference
27 Aug 2024 //
GLOBENEWSWIRE
ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
09 Aug 2024 //
GLOBENEWSWIRE
ProKidney Closes $140 Million Public Offering And Direct Offering
17 Jun 2024 //
GLOBENEWSWIRE
ProKidney Announces Pricing of its Upsized $130 Million Public Offering
11 Jun 2024 //
GLOBENEWSWIRE
ProKidney Announces $125M Public And Registered Direct Share Offerings
10 Jun 2024 //
GLOBENEWSWIRE
ProKidney to Participate in the Jefferies Global Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
ProKidney To Host KOL Event On Diabetes CKD Landscape, Phase 2 Data
21 May 2024 //
GLOBENEWSWIRE
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
10 May 2024 //
GLOBENEWSWIRE
ProKidney Announces Key Leadership Appointments Strengthening Clinical
25 Mar 2024 //
GLOBENEWSWIRE
ProKidney Reports Full Year 2023 Financial Results
21 Mar 2024 //
GLOBENEWSWIRE
ProKidney to Participate in Jefferies Biotech on the Bay Summit
29 Feb 2024 //
GLOBENEWSWIRE
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer
30 Nov 2023 //
GLOBENEWSWIRE
ProKidney to Participate in a Fireside Chat at the Evercore Conference
21 Nov 2023 //
GLOBENEWSWIRE
ProKidney Reports Third Quarter Financial Results
14 Nov 2023 //
GLOBENEWSWIRE
ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial
13 Nov 2023 //
GLOBENEWSWIRE
ProKidney Announces Four Abstracts Selected for Presentation
30 Oct 2023 //
GLOBENEWSWIRE
ProKidney to Participate in Fireside Chat at the Morgan Stanley Conference
05 Sep 2023 //
GLOBENEWSWIRE
ProKidney Reports Second Quarter Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
ProKidney Announces Closing of Purchase of Manufacturing Facility in NC
18 Jul 2023 //
GLOBENEWSWIRE
ProKidney Appoints Bruce Culleton, MD, as Executive Vice President
17 Jul 2023 //
GLOBENEWSWIRE
ProKidney drops $25.5M on NC cell therapy manufacturing site
14 Jun 2023 //
FIERCE PHARMA
ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
13 Jun 2023 //
GLOBENEWSWIRE
ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
ProKidney Reports First Quarter Financial Results & Recent Corporate Highlights
11 May 2023 //
GLOBENEWSWIRE
ProKidney to Present at the BofA Securities Health Care Conference 2023
04 May 2023 //
GLOBENEWSWIRE
ProKidney Reports Fourth Quarter Financial Results
28 Mar 2023 //
GLOBENEWSWIRE
ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference
03 Mar 2023 //
GLOBENEWSWIRE
CVS partners with ProKidney to enroll patients for phase 3 trial
02 Feb 2023 //
FIERCE BIOTECH
ProKidney Announces Publication of Trial Design for Phase 2 Trial of REACT
10 Jan 2023 //
GLOBENEWSWIRE
ProKidney to Present at the J.P. Morgan 41st Annual Healthcare Conference
21 Dec 2022 //
GLOBENEWSWIRE
ProKidney Reports 3Q 2022 Financial Results and Recent Corporate Highlights
14 Nov 2022 //
GLOBENEWSWIRE
ProKidney Receives Allowance from the UK MHRA for proact 1 (REGEN-006)
03 Nov 2022 //
GLOBENEWSWIRE
ProKidney Announces Multiple Abstracts Selected for Presentation at th ASN
14 Oct 2022 //
GLOBENEWSWIRE
ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit
23 Sep 2022 //
GLOBENEWSWIRE
ProKidney to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
08 Sep 2022 //
PRESS RELEASE
ProKidney Appoints Glenn Schulman as SVP of Investor Relations
31 Aug 2022 //
GLOBENEWSWIRE
ProKidney Strengthens Board of Directors with Appointments
11 Aug 2022 //
GLOBENEWSWIRE
ProKidney Corp. Reports Q2 2022 Rusult and Provides Business Update
11 Aug 2022 //
GLOBENEWSWIRE
ProKidney Appoints Kerry Cooper, M.D., as Senior VP of Medical Affairs
20 Jul 2022 //
GLOBENEWSWIRE
ProKidney to List on the Nasdaq Following Business Combination
12 Jul 2022 //
GLOBENEWSWIRE
ProKidney Corroborates Mechanism of Action of REACT with Cell Marker Analysis
23 Jun 2022 //
GLOBENEWSWIRE
ProKidney Announces Mfg Efficiency Initiatives and Supply Chain Streamlining
15 Jun 2022 //
GLOBENEWSWIRE
Observed Safety Profile Supports Bilateral Dosing of ProKidney`s REACT-007
07 Jun 2022 //
GLOBENEWSWIRE
ProKidney to present at upcoming investor conferences
20 May 2022 //
GLOBENEWSWIRE
ProKidney highlights key registrational program elements supporting REACT
03 May 2022 //
GLOBENEWSWIRE
ProKidney Appoints Libbie Parker McKenzie, MD, FASN as Chief Medical Officer
28 Apr 2022 //
GLOBENEWSWIRE
ProKidney and SCS Holdings to Host Analyst and Investor Day on April 28, 2022
18 Apr 2022 //
GLOBENEWSWIRE
ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT
12 Apr 2022 //
GLOBENEWSWIRE
ProKidney Appoints Todd C. Girolamo as General Counsel
28 Mar 2022 //
GLOBENEWSWIRE
ProKidney to Present REACT® at 4th Annual CKD Summit
01 Mar 2022 //
GLOBENEWSWIRE
